PetMed Express, Inc. PETS

NASDAQRetail TradeUnited States

$0.9402-0.05 (-4.96%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 0.940.99
52-week range: 0.934.10

Financial health

– / 5

Analyst view · 1 firms

Sell0 buy · 0 hold · 1 sell

Avg. target $1.40 (+48.9%)

Prices may be delayed and are for informational purposes only - not investment advice.

PetMed Express, Inc. PETS

NASDAQRetail TradeUnited States

$0.9402-0.05 (-4.96%)

Market closed· Nov 13, 2026, 9:00 PM UTC· USD · Data may be delayed

Day's range: 0.940.99
52-week range: 0.934.10

Financial health

– / 5

Analyst view · 1 firms

Sell0 buy · 0 hold · 1 sell

Avg. target $1.40 (+48.9%)

Valuation from filings

Calculated from the tables below and the current price ($0.9402) · LTM · 2026/9 · 2026-09-30

P/E: —EPS $-1.28
P/B: 1.19BV/share $0.79
P/S: 0.12Sales/share $7.54
Return on equity: -161.3%Net income / equity
Net margin: -17.0%Operating margin -18.0%
Free cash flow yield: -117.8%Free cash flow / market cap

Revenue and net income

Fiscal year · $ millions · net margin below

RevenueNet Income

Financial statements

$ thousands · Under each value: change against a year earlier

Upgrade to MakklerPRO to see every row.Upgrade to MakklerPRO

Fiscal year	2022	2023	2024	2025	2026	LTM
Income Statement
Revenue	272,282	247,569-9%	274,095+11%	226,972-17%	179,021-21%	160,262
Cost of Revenue
Gross Profit
Operating expenses
Operating Income
EBITDA
Pre-tax income
Income tax (expense) / benefit
Net Income	18,716	5,140-73%	(7,464)turned to a loss	(6,271)-16%	(57,286)+814%	(27,193)
Earnings per share ($)
Margins
Gross margin
Operating margin
EBITDA margin
Net margin

Taken from the company's own 10-K and 10-Q filings via the SEC's XBRL data service. The "LTM" column is the last completed fiscal year plus the current year to date, minus the same period a year earlier. Lines a company tags with a non-standard label are left blank rather than filled with an approximation. Not investment advice.